ARWR Stock Analysis: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$61.03
-1.89 (-3.00%)
▼
5d:
+0.43%
30d:
-6.25%
90d:
-8.07%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
ARWR is down 9.6% this week, but smart money is accumulating calls. Top strike: $65 2026-03-20 with 2,158 OI. Call ratio: 88% View Scanner →
Strength: 8.6/10
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARWR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ARWR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $61.03, which is considered fair relative to its 30-day fair value range of $56.97 to $63.14.
Technical Outlook: Technically, ARWR is in a uptrend. Immediate support is located at $54.89, while resistance sits at $64.86. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: ARWR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $81.09 (+32.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARWR is in a uptrend. Immediate support is located at $54.89, while resistance sits at $64.86. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: ARWR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $81.09 (+32.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$56.97 -
$63.14
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 32.9% below Wall St target ($81.09)
Fair Price Analysis
30-Day Fair Range
$56.97 -
$63.14
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$54.89
Resistance Level
$64.86
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.20
Wall Street Target
$81.09
(+32.9%)
Revenue Growth (YoY)
10461.3%
Earnings Growth (YoY)
9.8%
Profit Margin
18.5%
Share & Embed Analysis
Last updated: April 03, 2026 6:21 PM ET
Data refreshes hourly during market hours. Next update: 7:21 PM
Data refreshes hourly during market hours. Next update: 7:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
James C Hamilton
SELL
10000 shares
2026-03-05
James C Hamilton
SELL
40164 shares
2026-01-05
Patrick O'brien
SELL
49493 shares
2026-01-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
